Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00702104|
Recruitment Status : Completed
First Posted : June 20, 2008
Last Update Posted : May 14, 2013
RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat.
PURPOSE: This research study is looking at whether patients who are being screened for prostate cancer have been previously screened.
|Condition or disease||Intervention/treatment|
|Prostate Cancer||Other: survey administration|
- To determine the degree to which patients who are being screened for prostate cancer have been previously screened.
OUTLINE: Participants complete questions on a survey about prior prostate-specific antigen blood tests done for the purpose of screening for prostate cancer and are asked about their pastor, church, and how they heard about the SELECT study to determine the degree to which African-American men in a church-going population have been previously screened.
|Study Type :||Observational|
|Observational Model:||Ecologic or Community|
|Official Title:||PSA Screening of African-American Men in The San Francisco Area|
|Study Start Date :||January 2003|
|Primary Completion Date :||January 2008|
- Degree to which patients who are being screened for prostate cancer have been previously screened
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00702104
|United States, California|
|UCSF Helen Diller Family Comprehensive Cancer Center|
|San Francisco, California, United States, 94115|
|Principal Investigator:||Mack Roach, MD||University of California, San Francisco|